Computational methods have transformed the field of drug discovery, which significantly helped in the development of new treatments. Nowadays, researchers are exploring a wide ranger of opportunities to identify new compounds using machine learning. We conducted a comparative study between multiple models capable of predicting compounds to target non-small cell lung cancer, we focused on integrating protein expressions to identify potential compounds that exhibit a high efficacy in targeting lung cancer cells. A dataset was constructed based on the trials available in the ChEMBL database. Then, molecular descriptors were calculated to extract structure-activity relationships from the selected compounds and feed into several machine learning models to learn from. We compared the performance of various algorithms. The multilayer perceptron model exhibited the highest F1 score, achieving an outstanding value of 0,861. Moreover, we present a list of 10 drugs predicted as active in lung cancer, all of which are supported by relevant scientific evidence in the medical literature. Our study showcases the potential of combining protein expression analysis and machine learning techniques to identify novel drugs. Our analytical approach contributes to the drug discovery pipeline, and opens new opportunities to explore and identify new targeted therapies.
Hanafi et al. (Fri,) studied this question.